Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry)-Reference-Cited by-同舟云学术

Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry)

Published:2017-03 Issue: Volume:231 Page:54-60
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Godino Cosmo,Chiarito Mauro,Donahue Michael,Testa Luca^ORCID,Colantonio Riccardo,Cappelletti Alberto,Monello Alberto^ORCID,Magni Valeria,Milazzo Diego,Parisi Rosario,Nicolino Annamaria,Moshiri Shahram,Fattori Rossella,Aprigliano Gianfranco,Palloshi Altin,Caramanno Giuseppe,Montorfano Matteo,Bedogni Francesco,Briguori Carlo,Margonato Alberto,Colombo Antonio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Why are we still using coronary bare-metal stents?;Morice;J. Am. Coll. Cardiol.,2013

2. 2014 ESC/EACTS Guidelines on myocardial revascularization

3. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions;Carrié;J. Am. Coll. Cardiol.,2012

4. Early vessel healing of the Avantgarde cobalt-chromium coronary stent: the ON-GARDE OCT study;Prati;J. Cardiovasc. Med. (Hagerstown),2013

5. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation;Moretti;EuroIntervention,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside;Cardiovascular Research;2022-07-05

2. Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era;World Journal of Cardiology;2021-08-26

3. The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile;Expert Review of Medical Devices;2020-03-18

4. Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions;International Journal of Cardiology;2020-02

5. Bleeding risk factors in patients with acute coronary syndrome: data from observational studies ORACUL II;Russian Journal of Cardiology;2019-04-13